HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Simoneau, J.-A. Articles by Warden, C. H. Search for Related Content PubMed PubMed Citation Articles by Simoneau, J.-A. Articles by Warden, C. H.

Overexpression of muscle uncoupling protein 2 content in human obesity associates with reduced skeletal muscle lipid utilization

^a Division of Kinesiology, Department of Social and Preventive Medicine, Laval University, Ste-Foy, Québec, Canada G1K 7P4
^b Department of Endocrinology, University of Pittsburgh, Pennsylvania 15261, USA
^c Rowe Program in Genetics and Departments of Pediatrics, Biological Chemistry, and Medicine, UC Davis, California 95616, USA

Uncoupling proteins (UCP) may influence thermogenesis. Since skeletal muscle plays an important role in energy homeostasis and substrate oxidation, this study was undertaken to test the hypotheses that skeletal muscle UCP2 content is altered in obesity and could be linked to basal energy expenditure, insulin sensitivity, or substrate oxidation within skeletal muscle under postabsorptive (fasting) conditions. To examine these possibilities, limb basal energy expenditure and respiratory quotient (bRQ) were measured in 18 obese nondiabetic (Ob) and lean individuals (L). Total body fat (%) ranged from 11% to 46%. In addition, insulin-stimulated rates of glucose disposal (Rd) were measured under euglycemic hyperinsulinemic conditions. Biopsy of vastus lateralis muscle was used to measure cytochrome c oxidase (COX) enzyme activity and UCP2 content. Whereas low muscle COX activity was found in the Ob compared to L (6.9±1.6 vs. 9.6±1.2 U/g; P<0.001), skeletal muscle UCP2 content in Ob was significantly higher than in L (48±9 vs. 33±12 arbitrary units/g; P<0.05). Moreover, UCP2 content was positively correlated with percent of total body fat (r=0.57; P<0.05) and bRQ (r=0.59; P<0.01), but not with visceral fat (r=0.17; P=0.49), basal energy expenditure (r=0.07; P=0.79) or Rd (r=-0.23; P=0.34). In summary, these results indicate that if development of obesity in humans is mediated by defective expression of UCP2 within skeletal muscle, then this effect is not observed in people with established obesity. The present study also suggests that skeletal muscle UCP2 content is not related to basal energy expenditure or insulin sensitivity in humans. However, the increased content of UCP2 within skeletal muscle in obesity appears to coincide with a reduced postabsorptive lipid utilization by muscle.—Simoneau, J.-A., Kelley, D. E., Neverova, M., Warden, C. H. Overexpression of muscle uncoupling protein 2 content in human obesity associates with reduced skeletal muscle lipid utilization. FASEB J. 12, 1739–1745 (1998)

Key Words: UCP • body fat • substrate utilization • insulin sensitivity • energy expenditure

This article has been cited by other articles:

				C. T. De Souza, E. P. Araujo, L. F. Stoppiglia, J. R. Pauli, E. Ropelle, S. A. Rocco, R. M. Marin, K. G. Franchini, J. B. Carvalheira, M. J. Saad, et al. Inhibition of UCP2 expression reverses diet-induced diabetes mellitus by effects on both insulin secretion and action FASEB J, April 1, 2007; 21(4): 1153 - 1163. [Abstract] [Full Text] [PDF]

				D. Bach, S. Pich, F. X. Soriano, N. Vega, B. Baumgartner, J. Oriola, J. R. Daugaard, J. Lloberas, M. Camps, J. R. Zierath, et al. Mitofusin-2 Determines Mitochondrial Network Architecture and Mitochondrial Metabolism. A NOVEL REGULATORY MECHANISM ALTERED IN OBESITY J. Biol. Chem., May 2, 2003; 278(19): 17190 - 17197. [Abstract] [Full Text] [PDF]

				D. E. Kelley and B. H. Goodpaster Skeletal Muscle Triglyceride: An aspect of regional adiposity and insulin resistance Diabetes Care, May 1, 2001; 24(5): 933 - 941. [Abstract] [Full Text]

				R. Fabris, E. Nisoli, A. M. Lombardi, C. Tonello, R. Serra, M. Granzotto, I. Cusin, F. Rohner-Jeanrenaud, G. Federspil, M. O. Carruba, et al. Preferential Channeling of Energy Fuels Toward Fat Rather Than Muscle During High Free Fatty Acid Availability in Rats Diabetes, March 1, 2001; 50(3): 601 - 608. [Abstract] [Full Text]

				S. Diano, H. F. Urbanski, B. Horvath, I. Bechmann, A. Kagiya, G. Nemeth, F. Naftolin, C. H. Warden, and T. L. Horvath Mitochondrial Uncoupling Protein 2 (UCP2) in the Nonhuman Primate Brain and Pituitary Endocrinology, November 1, 2000; 141(11): 4226 - 4238. [Abstract] [Full Text] [PDF]

				M. Boivin, A. Camirand, F. Carli, L. J. Hoffer, and J. E. Silva Uncoupling Protein-2 and -3 Messenger Ribonucleic Acids in Adipose Tissue and Skeletal Muscle of Healthy Males: Variability, Factors Affecting Expression, and Relation to Measures of Metabolic Rate J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1975 - 1983. [Abstract] [Full Text]

				T. L. Horvath, C. H. Warden, M. Hajos, A. Lombardi, F. Goglia, and S. Diano Brain Uncoupling Protein 2: Uncoupled Neuronal Mitochondria Predict Thermal Synapses in Homeostatic Centers J. Neurosci., December 1, 1999; 19(23): 10417 - 10427. [Abstract] [Full Text] [PDF]

				C. Pecqueur, M.-C. Alves-Guerra, C. Gelly, C. Levi-Meyrueis, E. Couplan, S. Collins, D. Ricquier, F. Bouillaud, and B. Miroux Uncoupling Protein 2, in Vivo Distribution, Induction upon Oxidative Stress, and Evidence for Translational Regulation J. Biol. Chem., March 16, 2001; 276(12): 8705 - 8712. [Abstract] [Full Text] [PDF]